ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings
  • Abstract Number: 3120 • 2016 ACR/ARHP Annual Meeting

    RA Net: A Systems Biology Approach to Identify Genes Regulating Pathogenic Pathways in Rheumatoid Arthritis (RA) Fibroblast-like Synoviocytes (FLS)

    Wei Wang1, RIchard Ainsworth2, Richard Stein2, Rizi Ai3 and Gary Firestein4, 1Chemistry and Biochemistry, University of California, San Diego, La Jolla, CA, 2UC San Diego, La Jolla, CA, 3Chemistry and Biochemistry, UC San Diego, La Jolla, CA, 4Medicine, UCSD, La Jolla, CA

    Background/Purpose: Rheumatoid arthritis (RA) remains a significant unmet need despite improved therapy. Defining the interlaced nature of gene regulation and disease pathogenesis using integrative systems…
  • Abstract Number: 3121 • 2016 ACR/ARHP Annual Meeting

    Specific Antibody Subphenotypes in Rheumatoid Arthritis Are Associated with Unique HLA-DRB1 Residues at Position 11

    Chikashi Terao1,2, Boel Brynedal3, Zuomei Chen4, Xia Jiang4, Helga Westerlind4, Monika Hansson5, Linda Mathsson-Alm6,7, Per Johan Jakobsson8, Karl Skriner9, Guy Serre10, Johan Rönnelid7, Leonid Padyukov8, Jane Worthington11, Lars Alfredsson4, Lars Klareskog8 and Soumya Raychaudhuri1,2,11, 1Departments of Genetics and Rheumatology, Brigham and Women'’s Hospital, Harvard Medical School, Boston, MA, 2Program in Medical and Population Genetics, Broad Institute, Boston, MA, 3Section of Epidemiology, Institute of Environmental Medicine, Karolinska Institutet, Karolinska, Sweden, 4Section of Epidemiology, Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden, 5Rheumatology Unit, Department of Medicine, Karolinska Institute, Karolinska University Hospital, Stockholm, Sweden, 6Thermo Fisher Scientific, Uppsala, Sweden, 7Department of Immunology Genetics and Pathology,Uppsala University, Uppsala, Sweden, 8Unit of Rheumatology, Department of Medicine, Karolinska Institutet and Karolinska University Hospital, Stockholm, Sweden, 9Humboldt University of Berlin, Berlin, Germany, 10Unité Différenciation Épidermique et Autoimmunité Rhumatoïde, Unité Mixte de Recherche, INSERM, Toulouse, France, 11Arthritis Research UK Centre for Genetics and Genomics, Centre for Musculoskeletal Research, Faculty of Biology, Medicine and Health, Manchester Academic Health Science Centre, The University of Manchester, Manchester, United Kingdom

    Background/Purpose:   Antibody to citrullinated peptides/proteins (ACPA) is specific feature of rheumatoid arthritis (RA) and seen in 50 to 70% of RA patients. Amino acid (AA)…
  • Abstract Number: 3122 • 2016 ACR/ARHP Annual Meeting

    Genome-Wide DNA Methylation Association Study of Hand Osteoarthritis

    Michelle S. Yau1,2, Roby Joehanes3, Yi-Hsiang Hsu3, Douglas P. Kiel4 and David T. Felson5, 1Institute for Aging Research, Hebrew SeniorLife, Harvard Medical School, Boston, MA, 2Clinical Epidemiology Research and Training Unit, Boston University School of Medicine, Boston, MA, 3Hebrew SeniorLife, Harvard Medical School, Boston, MA, 4Institute for Aging Research, Institute for Aging Research, Hebrew Senior Life, Harvard Medical School, Boston, MA, USA, Boston, MA, 5Arthritis Research UK Centre for Epidemiology, Institute of Inflammation and Repair, University of Manchester, Manchester, United Kingdom

    Background/Purpose: Heritability of hand osteoarthritis (OA) has been estimated to be as high as 65%.  Despite having a strong genetic component, genome-wide linkage and association…
  • Abstract Number: 3123 • 2016 ACR/ARHP Annual Meeting

    Rare Mediterranean Fever (MEFV) Gene Polymorphisms Are Associated with Ankylosing Spondylitis in Turkish and Iranian Population

    Zhixiu Li1, Servet Akar2, Handan Yarkan3, Pinar Cetin3, Gerçek Can3, Gökce Kenar3, Omer Nuri Pamuk4, Yavuz Pehlivan5, Katie Cremin6, Erika De Guzman1, Jessica Harris1, Ahmad Reza Jamshidi7, Mahdi Vojdanian7, Nooshin Ahmadzadeh7, Mahdi Mahmoudi7, Matthew A. Brown1 and Nurullah Akkoc3, 1Translational Genomics Group, Institute of Health and Biomedical Innovation, Queensland University of Technology, Translational Research Institute, Brisbane, Australia, Brisbane, Australia, 2Department of Rheumatology, İzmir Katip Çelebi University, School of Medicine, İzmir, Turkey, İzmir, Turkey, 3Department of Rheumatology, Dokuz Eylul University, Faculty of Medicine, İzmir, Turkey, İzmir, Turkey, 4Department of Rheumatology, Trakya University Medical Faculty, Edirne, Turkey, Edirne, Turkey, 5Department of Rheumatology, Uludag University Medical Faculty, Bursa, Turkey, Bursa, Turkey, 6The University of Queensland Diamantina Institute, Translational Research Institute, Brisbane, Australia, Brisbane, Australia, 7Rheumatology Research Center, Tehran University of Medical Sciences, Tehran, Iran, Tehran, Iran (Islamic Republic of)

    Background/Purpose: Ankylosing spondylitis (AS) is a highly heritable inflammatory arthritis common in both Turkish and Iranian populations. Familial Mediterranean Fever (FMF) is an autosomal recessive…
  • Abstract Number: 3124 • 2016 ACR/ARHP Annual Meeting

    Huntingtin Interacting Protein 1 (Hip1) Is a New Arthritis Severity Gene

    Teresina Laragione1, Percio Gulko1 and Max Brenner2, 1Medicine/Rheumatology, Icahn School of Medicine at Mount Sinai, New York, NY, 2Feinstein Institute for Medical Research, Manhasset, NY

    Background/Purpose:  Cia25/Pia42 is an arthritis severity and joint damage quantitative trait locus on rat chromosome 12 previously identified in an intercross between MHC identical but…
  • Abstract Number: 3125 • 2016 ACR/ARHP Annual Meeting

    Secular Trend of Premature Mortality in Gout: A Contrast from Rheumatoid Arthritis

    Sharan K. Rai1,2, Leo Lu3, Yuqing Zhang4 and Hyon K. Choi5, 1Division of Rheumatology, Allergy, and Immunology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, 2Arthritis Research Canada, Vancouver, BC, Canada, 3Allergy, Immunology, and Rheumatology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, 4Clinical Epidemiology and Training Unit, Boston University School of Medicine, Boston, MA, 5Rheumatology, Allergy, and Immunology, Massachusetts General Hospital, Harvard Medical School, Boston, MA

    Background/Purpose: Gout and rheumatoid arthritis (RA), the two most common inflammatory arthritides, are both associated with premature mortality. General population-based studies have found substantially reduced…
  • Abstract Number: 3126 • 2016 ACR/ARHP Annual Meeting

    Computational Polarizing Microscopy: A Novel Method to Detect Birefringent Crystals Using Lens-Free on-Chip Microscopy

    Seung Yoon Lee1, Yibo Zhang2, Daniel E. Furst1, Ann Rosenthal3, Ralph Schumacher4, John FitzGerald1 and Aydogan Ozcan2, 1Division of Rheumatology, Department of Internal Medicine, University of California Los Angeles, David Geffen School of Medicine, Los Angeles, CA, 2Electrical Engineering Department, University of California Los Angeles, School of Engineering, Los Angeles, CA, 3Division of Rheumatology, Department of Internal Medicine, Medical College of Wisconsin, Milwaukee, WI, 4Division of Rheumatology, Department of Internal Medicine, University of Pennsylvania, Perelman School of Medicine, Philadelphia, PA

    Background/Purpose: A compensated polarizing microscopy has been used for detecting monosodium urate (MSU) or calcium pyrophosphate dihydrate (CPPD) crystals to confirm the diagnosis of gout…
  • Abstract Number: 3127 • 2016 ACR/ARHP Annual Meeting

    Ultrasound Evaluation of the Achilles Tendon in Tophaceous Gout: A Case-Control Study

    Matthew Carroll1, Nicola Dalbeth2, Mark Boocock1 and Keith Rome1, 1School of Clinical Sceince, Health & Rehabilitation Research Institute, AUT University, Auckland, New Zealand, 2University of Auckland, Auckland, New Zealand

    Ultrasound Evaluation of the Achilles Tendon in Tophaceous Gout: A Case-Control Study Background/Purpose: Tendon involvement in the lower limbs in gout is frequent.  Tophus deposition…
  • Abstract Number: 3128 • 2016 ACR/ARHP Annual Meeting

    A Longitudinal Dual Energy Computed Tomography Study on the Effect of Urate Lowering Therapies on the Reduction of Tophus Burden in Patients with Chronic Gout

    Hanna Ellmann1, Sara Bayat1, Isabelle Oliveira1, Matthias Englbrecht2,3, Elizabeth Araujo4, Alexander Cavallaro5, Silvana Mendonca6, Michael Lell5, Bernhard Manger2, Georg Schett7 and Juergen Rech7, 1Medical Department 3, Rheumatology & Clinical Immunology, Friedrich-Alexander-University Erlangen-Nürnberg (FAU), Erlangen, Germany, 2Department of Internal Medicine 3, Rheumatology & Clinical Immunology, Friedrich-Alexander-University Erlangen-Nürnberg (FAU), Erlangen, Germany, 3Department of Internal Medicine 3, University of Erlangen-Nuremberg, Erlangen, Germany, 4Medical Department 3; Rheumatology & Clinical Immunology, Friedrich-Alexander-University Erlangen-Nürnberg (FAU), Erlangen, Germany, 5Department of Radiology, University of Erlangen-Nuremberg, Department of Radiology, Erlangen, Germany, 6Americas Medical City, Rio de Janeiro, Brazil, 7Department of Internal Medicine 3 – Rheumatology and Immunology, Universitätsklinikum Erlangen, Friedrich-Alexander-University Erlangen-Nürnberg (FAU), Erlangen, Germany

    Background/Purpose: Dual energy computed tomography (DECT) allows reliably detecting and quantifying tophus burden in patients with chronic gout. Longitudinal studies on the effect of uric…
  • Abstract Number: 3129 • 2016 ACR/ARHP Annual Meeting

    The Pharmacokinetics of Oxypurinol in Patients Treated with Hemodialysis and Allopurinol

    Matthew Doogue1, Dan Wright2, Nick Cross3, John Irvine3, Peter T. Chapman4, Murray Barclay5 and Lisa K. Stamp1, 1University of Otago, Christchurch, New Zealand, 2School of Pharmacy, University of Otago, Dunedin, New Zealand, 3Nephrology, Christchurch Hospital, Christchurch, New Zealand, 4Christchurch Hospital, Christchurch, New Zealand, 5Medicine, University of Otago, Christchurch, New Zealand

    Background/Purpose: Allopurinol is recommended as a first-line pharmacologic urate-lowering therapy in gout. Oxypurinol, the active metabolite of allopurinol, is entirely cleared by the kidneys. Oxypurinol…
  • Abstract Number: 3130 • 2016 ACR/ARHP Annual Meeting

    Development and Pilot Testing of an Online Educational Tool for Gout Patients — Mygoutcare®

    Puja Khanna1, Aaron Rankin2, Veronica Berrocal3, Larry An4 and Dinesh Khanna5, 1Rheumatology, University of Michigan, Ann Arbor, MI, 2Medicine Rheumatology, University of Michigan, Ann Arbor, MI, 3Biostatistics, University of Michigan, Ann Arbor, MI, 4Medicine, University of Michigan, Ann Arbor, MI, 5University of Michigan, Ann Arbor, MI

    Background/Purpose:  Recent management guidelines for gout have identified several unmet educational needs in gout patients. Qualitative studies have documented the paucity of patient-focused materials which…
  • Abstract Number: 3131 • 2016 ACR/ARHP Annual Meeting

    Pregabalin Is More Effective in Treating Hand Osteoarthritis Pain Than Duloxetine or Placebo: A Double-Blind Randomized Controlled Trial

    Nidhi Sofat1, Abiola Harrison2, Salma Ayis3, Patrick Kiely4, Thomas Richard Barrick5 and Franklyn Howe6, 1Basic Medical Sciences, St. George's, University of London, London, United Kingdom, 2Rheumatology, Mailpoint J1A, St George's, University of London, London, United Kingdom, 3Department if Statistics, Division of Health & Social Care Research, Guy's Campus, King's College London, London, United Kingdom, 4Rheumatology Dept, St Georges Hospital, London, Great Britain, 5Clinical Sciences, St George's, University of London, London, United Kingdom, 6Cardiovascular and Cell Sciences, St George's, University of London, London, United Kingdom

    Background/Purpose: A prospective, randomized, double-blind, placebo-controlled trial from 42 primary care and rheumatology clinics in the UK. We recruited 85 participants: 65 with hand OA…
  • Abstract Number: 3132 • 2016 ACR/ARHP Annual Meeting

    Protective Effects of Replacing Sedentary Time with Light and Moderate to Vigorous Physical Activity on Functional Limitation in Knee OA

    Daniel White, Department of Physical Therapy, University of Delaware, Newark, DE

    Background/Purpose: Physical activity protects the development of functional limitation in knee osteoarthritis (OA).  But little is known about the protective effects of physical activity intensity,…
  • Abstract Number: 3133 • 2016 ACR/ARHP Annual Meeting

    Association Between Quantitatively Measured Infrapatellar Fat Pad High Signal Intensity Alteration and Knee Structural and Symptomatic Abnormalities in Patients with Symptomatic Knee Osteoarthritis

    WEIYU HAN1, Graeme Jones2 and Changhai Ding2, 1Menzies Institute for Medical Research, University of Tasmania, Hobart, Australia, 2Musculoskeletal Unit, Menzies Institute for Medical Research, University of Tasmania, Hobart, Australia

    Background/Purpose: Infrapatellar fat pad (IPFP), a local adipose tissue, may have important contributions to knee osteoarthritis (OA). IPFP signal intensity alterations on MRI may represent…
  • Abstract Number: 3134 • 2016 ACR/ARHP Annual Meeting

    Hydroxychloroquine Is Not Effective in Reducing Symptoms of Hand Osteoarthritis: Results from a Placebo-Controlled Randomised Trial

    Sarah R. Kingsbury1, Puvan Tharmanathan2, Ada Keding3, Sarah Ronaldson3, Andrew Grainger4, Richard J. Wakefield5, Catherine Arundel3, Fraser Birrell6, Michael Doherty7, Tonia Vincent8, Fiona E Watt9, Krysia Dziedzic10, Terence W. O'Neill11, Nigel K Arden12, David L Scott13, John Dickson14, Toby Garrood15, Michael Green16,17, Ajit Menon18, Tom Sheeran19, David Torgerson3 and Philip G. Conaghan4, 1Section of Musculoskeletal Disease, Chapel Allerton Hospital, Section of Musculoskeletal Disease, Leeds Institute of Molecular Medicine, Leeds, United Kingdom, 2University of York, York, United Kingdom, 3Health Sciences, University of York, York, United Kingdom, 4Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, Leeds, United Kingdom, 5University of Leeds, Leeds, United Kingdom, 6Institute for Cellular Medicine, Newcastle University, Newcastle upon Tyne, United Kingdom, 7Academic Rheumatology, University of Nottingham, Nottingham, Great Britain, 8University of Oxford, London, Great Britain, 9Kennedy Institute of Rheumatology, University of Oxford, Oxford, United Kingdom, 10Institute for Primary Care and Health Sciences, Keele University, Staffordshire, United Kingdom, 11Arthritis Research UK Centre for Epidemiology, The University of Manchester, Centre for Musculoskeletal Research, Manchester, United Kingdom, 12Oxford NIHR Musculoskeletal Biomedical Research Unit, University of Oxford, Oxford, United Kingdom, 13Department of Rheumatology, King's College London, London, United Kingdom, 14South Tees Hospitals NHS Foundation Trust, Middlesbrough, United Kingdom, 15Rheumatology, Guy's and St. Thomas' NHS Foundation Trust, London, United Kingdom, 16York Teaching Hospital NHS Foundation Trust, York, United Kingdom, 17Harrogate and District NHS Foundation Trust, Harrogate, United Kingdom, 18Haywood Hospital, Stoke-On-Trent, United Kingdom, 19Cannock Chase Hospital, Cannock, United Kingdom

    Background/Purpose:  Synovitis is prevalent in OA and associated with pain. Hydroxychloroquine (HCQ) is used routinely for treating synovitis in inflammatory arthritis. The primary aim of…
  • « Previous Page
  • 1
  • …
  • 1623
  • 1624
  • 1625
  • 1626
  • 1627
  • …
  • 2425
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology